Nuveen Asset Management, LLC Vanda Pharmaceuticals Inc. Transaction History

Nuveen Asset Management, LLC

  • $329 Billion
  • Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 302,650 shares of VNDA stock, worth $1.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
302,650
Previous 154,750 95.57%
Holding current value
$1.61 Million
Previous $653,000 90.35%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$3.47 - $4.61 $513,213 - $681,819
147,900 Added 95.57%
302,650 $1.24 Million
Q4 2023

Feb 14, 2024
BUY
$3.38 - $4.58 $4,853 - $6,576
1,436 Added 0.94%
154,750 $653,000
Q3 2023

Nov 14, 2023
SELL
$4.28 - $6.57 $1.06 Million - $1.62 Million
-246,689 Reduced 61.67%
153,314 $662,000
Q2 2023

Aug 14, 2023
SELL
$5.9 - $6.95 $1.14 Million - $1.35 Million
-193,685 Reduced 32.62%
400,003 $2.64 Million
Q1 2023

May 15, 2023
BUY
$6.18 - $7.99 $130,231 - $168,373
21,073 Added 3.68%
593,688 $4.03 Million
Q4 2022

Feb 14, 2023
SELL
$6.87 - $10.96 $3.48 Million - $5.55 Million
-506,276 Reduced 46.93%
572,615 $4.23 Million
Q3 2022

Nov 14, 2022
BUY
$9.44 - $11.76 $860,040 - $1.07 Million
91,106 Added 9.22%
1,078,891 $10.7 Million
Q2 2022

Aug 15, 2022
BUY
$9.31 - $11.84 $65,337 - $83,093
7,018 Added 0.72%
987,785 $10.8 Million
Q1 2022

May 16, 2022
SELL
$10.84 - $16.55 $169,114 - $258,196
-15,601 Reduced 1.57%
980,767 $11.3 Million
Q4 2021

Feb 14, 2022
BUY
$15.69 - $21.14 $2.69 Million - $3.63 Million
171,565 Added 20.8%
996,368 $15.6 Million
Q3 2021

Nov 12, 2021
BUY
$15.35 - $21.27 $9.03 Million - $12.5 Million
588,107 Added 248.47%
824,803 $14.1 Million
Q2 2021

Aug 16, 2021
SELL
$15.71 - $21.51 $142,222 - $194,730
-9,053 Reduced 3.68%
236,696 $5.09 Million
Q1 2021

May 17, 2021
SELL
$13.42 - $20.28 $85,740 - $129,568
-6,389 Reduced 2.53%
245,749 $3.69 Million
Q4 2020

Feb 16, 2021
BUY
$9.77 - $13.81 $5,764 - $8,147
590 Added 0.23%
252,138 $3.31 Million
Q3 2020

Nov 16, 2020
SELL
$9.32 - $12.02 $213,390 - $275,209
-22,896 Reduced 8.34%
251,548 $2.43 Million
Q2 2020

Aug 14, 2020
SELL
$9.66 - $12.02 $5.07 Million - $6.31 Million
-525,247 Reduced 65.68%
274,444 $3.14 Million
Q1 2020

May 14, 2020
SELL
$7.5 - $16.8 $1.65 Million - $3.7 Million
-220,168 Reduced 21.59%
799,691 $8.28 Million
Q4 2019

Feb 14, 2020
SELL
$12.38 - $17.47 $1.79 Million - $2.52 Million
-144,247 Reduced 12.39%
1,019,859 $16.7 Million
Q3 2019

Nov 14, 2019
BUY
$12.27 - $15.79 $2.63 Million - $3.38 Million
213,959 Added 22.52%
1,164,106 $15.5 Million
Q2 2019

Aug 15, 2019
BUY
$13.37 - $18.85 $12.7 Million - $17.9 Million
950,147 New
950,147 $13.4 Million

Others Institutions Holding VNDA

# of Institutions
148
Shares Held
49.6M
Call Options Held
49.1K
Put Options Held
107K
View Full List

About Vanda Pharmaceuticals Inc.

VNDA Quotes by TradingView
  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $301M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email